EHAB

Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.

Wall Street analysts forecast EHAB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHAB is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Enhabit Inc revenue for the last quarter amounts to 263.60M USD, increased 3.94 % YoY.

Enhabit Inc. EPS for the last quarter amounts to 0.22 USD, decreased -110.00 % YoY.

Enhabit Inc (EHAB) has 10700 emplpoyees as of December 16 2025.

Today EHAB has the market capitalization of 490.38M USD.